The impact of COVID-19 on acute stroke care in Belgium

• Published in: Acta neurologica Belgica 2021-10, Vol.121 (5), p.1251-1258
• Main Authors: Raymaekers, Vincent, Demeestere, Jelle, Bellante, Flavio, De Blauwe, Sofie, De Raedt, Sylvie, Dusart, Anne, Jodaitis, Lise, Lemmens, Robin, Loos, Caroline, Noémie, Ligot, Rutgers, Matthieu P., Vandervorst, Fenne, Vanhooren, Geert, Yperzeele, Laetitia, Nogueira, Raul G., Nguyen, Thanh N., Vanacker, Peter
• Format: Article
• Language: English
• Subjects: Biomedical and Life Sciences; Biomedicine; Medicine/Public Health; Neurology; Neuroradiology; Neurosciences; Original; Original Article
• ISSN: 0300-9009; 2240-2993
• DOI: 10.1007/s13760-021-01726-x

A worldwide decline in stroke hospitalizations during the COVID-19 pandemic has been reported. Information on stroke care during the pandemic in Belgium is lacking. This study aims to analyze the impact of COVID-19 on acute stroke care in eight Belgian stroke centers. This Belgian study is part of an international observational and retrospective study in 70 countries and 457 stroke centers. We compared volumes of COVID-19 and stroke hospitalizations, intravenous thrombolysis and endovascular treatment rates, acute treatment time intervals and functional outcome at 90 days during the first wave of the pandemic to two control intervals (March–May 2019 and December–February 2020). From March 2020 to May 2020, 860 stroke patients were hospitalized. In the same time period, 2850 COVID-19 patients were admitted, of which 37 (1.3%) were diagnosed with a stroke. Compared to the months prior to the pandemic and the same time epoch one year earlier, stroke hospitalizations were reduced (relative difference 15.9% [ p  = 0.03] and 14.5% [ p  = 0.05], respectively). Despite a reduction in absolute volumes, there was no difference in the monthly proportion of thrombolysis or endovascular treatment provided to the overall stroke hospitalizations. Acute treatment time metrics did not change between COVID-19 pandemic and control time epochs. We found no difference in 90-day functional outcomes nor in mortality after stroke between patients admitted during the pandemic versus control periods. We found a decline in the volume of stroke hospitalizations during the first wave of the COVID-19 pandemic in Belgium. Stroke care quality parameters remained unchanged.